Cofoe Medical Technology Co., Ltd. disclosed in its Next Day Disclosure Return filed on 22 July 2026 that it repurchased 496,200 A-shares on the Shenzhen Stock Exchange the same day.

• Repurchase size and price range – Shares bought: 496,200 – Price range: RMB 50.60 – RMB 53.87 per share – Volume-weighted average price (per Section I Part B): RMB 52.61

• Cash outlay – Total consideration: RMB 26.11 million

• Capital structure impact – Repurchased shares represent 0.25 % of Cofoe Medical’s 201.70 million issued shares (excluding treasury shares) as of 30 June 2026. – Prior to the transaction, treasury shares totaled 7.20 million. – The 496,200 shares are slated for cancellation; until cancellation, they remain in treasury, leaving the company’s total issued share count at 208.90 million.

The company confirmed that the buyback was authorized by its board and executed in compliance with Shenzhen Stock Exchange regulations and the Hong Kong Listing Rules.